Predictive Oncology Stock Price on November 26, 2024
| POAI Stock | USD 0.81 0.03 3.85% |
Below is the normalized historical share price chart for Predictive Oncology extending back to April 09, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Predictive Oncology stands at 0.81, as last reported on the 29th of November, with the highest price reaching 0.81 and the lowest price hitting 0.75 during the day.
If you're considering investing in Predictive Stock, it is important to understand the factors that can impact its price. Predictive Oncology maintains Sharpe Ratio (i.e., Efficiency) of -0.0196, which implies the firm had a -0.0196% return per unit of risk over the last 3 months. Predictive Oncology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Predictive Oncology's insignificant Risk Adjusted Performance, coefficient of variation of (7,703), and Variance of 33.09 to confirm the risk estimate we provide.
As of now, Predictive Oncology's Common Stock Total Equity is decreasing as compared to previous years. The Predictive Oncology's current Common Stock Shares Outstanding is estimated to increase to about 4.2 M, while Total Stockholder Equity is projected to decrease to under 5 M. . The Predictive Oncology's current Price Earnings To Growth Ratio is estimated to increase to 0.03, while Price To Sales Ratio is projected to decrease to 7.05. Predictive Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of January 2018 | 200 Day MA 1.4013 | 50 Day MA 0.7207 | Beta 1.145 |
Predictive |
Sharpe Ratio = -0.0196
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | POAI |
Estimated Market Risk
| 5.85 actual daily | 52 52% of assets are less volatile |
Expected Return
| -0.11 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Predictive Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Predictive Oncology by adding Predictive Oncology to a well-diversified portfolio.
Price Book 2.6364 | Enterprise Value Ebitda (0.51) | Price Sales 2.9647 | Shares Float 6.4 M | Wall Street Target Price 3 |
Related Headline
Microbot Medical Headline on 26th of November 2024
Surgical Robots Market to Grow by USD 14.02 Billion , Rising... by finance.yahoo.com
Report with the AI impact on market trends - The global surgical robots market size is estimated to grow by USD 14.02 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 27.17 percent during the forecast period. High adoption due to convenience is driving market growth, with a trend towards high demand from developing countries. However, cost and affordability associated with surgical robots poses a challenge.Key market players include Accuray Inc., Asensus Surg
Predictive Oncology Valuation on November 26, 2024
It is possible to determine the worth of Predictive Oncology on a given historical date. On November 26, 2024 Predictive was worth 0.76 at the beginning of the trading date compared to the closed value of 0.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Predictive Oncology stock. Still, in general, we apply an absolute valuation method to find Predictive Oncology's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Predictive Oncology where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Predictive Oncology's related companies.
| Open | High | Low | Close | Volume | |
| 0.79 | 0.79 | 0.73 | 0.75 | 99,068 | |
11/26/2024 | 0.76 | 0.85 | 0.75 | 0.80 | 248,896 |
| 0.79 | 0.83 | 0.77 | 0.78 | 82,212 |
| Backtest Predictive Oncology | | | Predictive Oncology History | | | Predictive Oncology Valuation | Previous | Next |
Predictive Oncology Trading Date Momentum on November 26, 2024
| On November 27 2024 Predictive Oncology was traded for 0.78 at the closing time. The top price for the day was 0.83 and the lowest listed price was 0.77 . The trading volume for the day was 82.2 K. The trading history from November 27, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.50% . The trading delta at closing time against the current closing price is 1.25% . |
Predictive Oncology Fundamentals Correlations and Trends
By evaluating Predictive Oncology's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Predictive Oncology's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Predictive financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Predictive Oncology Stock history
Predictive Oncology investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Predictive is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Predictive Oncology will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Predictive Oncology stock prices may prove useful in developing a viable investing in Predictive Oncology
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4 M | 4.2 M | |
| Net Loss | -23.2 M | -24.3 M |
Predictive Oncology Stock Technical Analysis
Predictive Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Predictive Oncology Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Predictive Oncology cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Predictive Oncology November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Predictive Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Predictive Oncology shares will generate the highest return on investment. By undertsting and applying Predictive Oncology stock market strength indicators, traders can identify Predictive Oncology entry and exit signals to maximize returns
Predictive Oncology Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Predictive Oncology's price direction in advance. Along with the technical and fundamental analysis of Predictive Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Predictive to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.30) | |||
| Total Risk Alpha | (0.95) | |||
| Treynor Ratio | (0.05) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |